Low-dose Digoxin
Cross-source consensus on Low-dose Digoxin from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Benefits
Dosage & preparation
Risks & contraindications
Evidence quality
Highlighted claims
- Low-dose digoxin did not significantly reduce the DECISION trial primary composite endpoint compared with placebo. — Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial
- The primary composite outcome was numerically lower with digoxin but did not reach statistical significance. — Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial
- Most patients started digoxin at 0.1 mg once daily, while one quarter started at 0.2 mg once daily. — Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial
- DECISION tested a low-dose digoxin strategy added to contemporary guideline-recommended therapy. — Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial
- Low-dose digoxin was generally well tolerated in the trial. — Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial